Literature DB >> 16211621

Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.

Katia Noyes1, Hangsheng Liu, Yue Li, Robert Holloway, Andrew W Dick.   

Abstract

We evaluated medical utilization and economic burden of self-reported Parkinson's disease (PD) on patients and society. Using the 1992-2000 Medicare Current Beneficiary Survey, we compared health care utilization and expenditures (in 2002 U.S. dollars) of Medicare subscribers with and without PD, adjusting for sociodemographic characteristics and comorbidities. PD patients used significantly more health care services of all categories and paid significantly more out of pocket for their medical services than other elderly (mean+/- SE, 5,532 dollars+/- 329 dollars vs. 2,187 dollars+/- 38 dollars; P<0.001). After adjusting for other factors, PD patients had higher annual health care expenses than beneficiaries without PD (18,528 dollars vs. 10,818 dollars; P<0.001). PD patients were more likely to use medical care (OR=3.77; 95% CI=1.44-9.88), in particular for long-term care (OR=3.80; 95% CI=3.02-4.79) and home health care (OR=2.08; 95% CI=1.76-2.46). PD is associated with a significant economic burden to patients and society. Although more research is needed to understand the relationship between PD and medical expenditures and utilization, these findings have important implications for health care providers and payers that serve PD populations. (c) 2005 Movement Disorder Society.

Entities:  

Mesh:

Year:  2006        PMID: 16211621     DOI: 10.1002/mds.20727

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  36 in total

1.  Gerontology forum: an update on the literature.

Authors: 
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

2.  Optimal frequency for measuring health care resource utilization in Parkinson's disease using participant recall: the FS-TOO resource utilization substudy.

Authors:  Patrick D Mauldin; Paulo Guimaraes; Roger L Albin; E Ray Dorsey; Jacquelyn L Bainbridge; Andrew Siderowf
Journal:  Clin Ther       Date:  2008-08       Impact factor: 3.393

3.  Costs of illness in a Russian cohort of patients with Parkinson's disease.

Authors:  Yaroslav Winter; Sonja von Campenhausen; Georgy Popov; Jens P Reese; Jens Klotsche; Kai Bötzel; Eugene Gusev; Wolfgang H Oertel; Richard Dodel; Alla Guekht
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 4.  Integrating Patient Concerns into Parkinson's Disease Management.

Authors:  Shen-Yang Lim; Ai Huey Tan; Susan H Fox; Andrew H Evans; Soon Chai Low
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

5.  Projection of the prevalence of Parkinson's disease in the coming decades: Revisited.

Authors:  Alexander Rossi; Kristin Berger; Honglei Chen; Douglas Leslie; Richard B Mailman; Xuemei Huang
Journal:  Mov Disord       Date:  2017-06-07       Impact factor: 10.338

Review 6.  The coming crisis: obtaining care for the growing burden of neurodegenerative conditions.

Authors:  E Ray Dorsey; Benjamin P George; Bruce Leff; Allison W Willis
Journal:  Neurology       Date:  2013-04-24       Impact factor: 9.910

7.  The effects of adapted tango on spatial cognition and disease severity in Parkinson's disease.

Authors:  Kathleen E McKee; Madeleine E Hackney
Journal:  J Mot Behav       Date:  2013-10-11       Impact factor: 1.328

Review 8.  Methodological issues in using multiple years of the Medicare current beneficiary survey.

Authors:  Becky A Briesacher; Jennifer Tjia; Chyke A Doubeni; Yong Chen; Sowmya R Rao
Journal:  Medicare Medicaid Res Rev       Date:  2012-02-08

9.  Can Valproic Acid Regulate Neurogenesis from Nestin+ Cells in the Adult Midbrain?

Authors:  Parisa Farzanehfar; Malcolm K Horne; Tim D Aumann
Journal:  Neurochem Res       Date:  2017-04-22       Impact factor: 3.996

10.  Randomized controlled clinical trial of "virtual house calls" for Parkinson disease.

Authors:  E Ray Dorsey; Vinayak Venkataraman; Matthew J Grana; Michael T Bull; Benjamin P George; Cynthia M Boyd; Christopher A Beck; Balaraman Rajan; Abraham Seidmann; Kevin M Biglan
Journal:  JAMA Neurol       Date:  2013-05       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.